Lytics Biopharma AS
Lytics Biopharma AS
Description
clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel therapy to fight cancer
Lytics Biopharma AS
Address
Sandakerveien 138, 0484 Oslo
Oslo, Oslo, Norway
Oslo, Oslo, Norway
Contact
post@lytixbiopharma.com
Description
clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel therapy to fight cancer
Matchmaking
Connect with Lytics Biopharma AS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways